Clinical Trial Update: Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab, temozolomide, and external beam radiotherapy as first-line therapy for newly diagnosed glioblastoma multiforme or gliosarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2020-09-21